Fulgent Genetics, Inc. Common Stock FLGT
$23.74
+27.22%
at last close
Analyst Consensus
- Consensus Rating
- Hold (0 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $19.00
- Implied Upside
- -20.0%
- Price Target Range
- $19.00 – $19.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-04 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $15 → $19 |
| 2026-05-05 | Piper SandlerDavid Westenberg |
Reiterates | Neutral | $30 → $15 |
| 2025-11-11 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $21 → $30 |
| 2025-08-05 | UBSLu Li |
Upgrades | Neutral → Buy | $20 → $30 |
| 2025-08-04 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $23 → $21 |
| 2025-05-06 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $16 → $23 |
| 2025-05-05 | Raymond JamesAndrew Cooper |
Reiterates | Outperform | $24 → $25 |
| 2025-03-04 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $22 → $16 |
| 2024-11-11 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $26 → $22 |
| 2024-03-06 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $28 → $25 |
| 2023-12-07 | UBSDan Leonard |
Initiates coverage on | Neutral | $35 |
| 2023-10-16 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $37 → $28 |
| 2023-03-02 | Credit SuisseDan Leonard |
Maintains | Outperform | $50 → $45 |
| 2022-12-08 | Piper SandlerDavid Westenberg |
Downgrades | Overweight → Neutral | $65 → $40 |
| 2022-11-18 | Raymond JamesAndrew Cooper |
Initiates coverage on | Outperform | $45 |
| 2022-11-14 | Credit SuisseDan Leonard |
Maintains | Outperform | $65 → $50 |
| 2022-11-14 | Piper SandlerDavid Westenberg |
Maintains | Overweight | $70 → $65 |
| 2022-08-25 | Credit SuisseDan Leonard |
Initiates coverage on | Outperform | $65 |
| 2022-05-16 | Piper SandlerDavid Westenberg |
Maintains | Overweight | $85 → $70 |
| 2022-01-25 | OppenheimerKevin DeGeeter |
Maintains | Outperform | $141 → $125 |
| 2021-08-10 | Credit SuisseKatie Tryhane |
Maintains | Underperform | $55 → $65 |
| 2021-03-05 | Piper SandlerSteven Mah |
Maintains | Overweight | $135 → $140 |
| 2021-02-01 | OppenheimerKevin DeGeeter |
Maintains | Outperform | $75 → $130 |
| 2021-01-08 | Credit SuisseErin Wilson |
Downgrades | Neutral → Underperform | — |
| 2020-11-24 | BTIGSung Ji Nam |
Downgrades | Buy → Neutral | — |
| 2020-09-25 | Credit SuisseKatie Tryhane |
Maintains | Neutral | $13 → $42 |
| 2020-08-20 | OppenheimerKevin DeGeeter |
Initiates coverage on | Outperform | $75 |
| 2020-07-27 | Piper SandlerSteven Mah |
Maintains | Overweight | $21 → $31 |
| 2020-06-17 | Piper SandlerSteven Mah |
Maintains | Overweight | $18 → $21 |
| 2020-05-29 | BTIGSung Ji Nam |
Initiates coverage on | Buy | $20 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $23.74
- Market Cap
- $663.27 million
- 52-Week Range
- $13.46 – $31.04
- Average Volume
- 311K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.